The Valley Desk

Clinical trial reportHead & neckPublished

Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Head & neck
Published
Subject terms
Humans; Head and Neck Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Carboplatin; Antineoplastic Combined Chemotherapy Protocols; Treatment Outcome; Aged; Middle Aged; Female; Male; Cetuximab
PubMed ID
40166973
Added to directory
Source checked

Report a correction or request removal